作为ASS1激活剂和瘤抑制剂的Spinosyn A衍生物
Xin-Yu Huang1, Xiao-He Liu2, Na Xu1
1Xiangya School of Pharmaceutical Sciences, Hunan Key Laboratory of Diagnostic and Therapeutic Drug Research for Chronic Diseases, Central South University, Changsha 410013, China.
Bioorganic & medicinal chemistry letters
|January 10, 2026
概括
斯皮诺辛A激活ASS1酶,显示出抗癌潜力. 对其结构的修改增强了其抑制瘤和激活ASS1的特性,这对于开发新的癌症疗法至关重要.
科学领域:
- 生物化学 生物化学
- 药用化学 医学化学
- 在瘤学瘤学.
背景情况:
- 一种农药Spinosad含有Spinosyn A,其已被证明具有抗繁殖作用.
- 氨酸酸合成酶1 (ASS1) 是抗癌疗法的验证标.
- 此前,Spinosyn A已被确定为ASS1.1的第一类激活剂.
研究的目的:
- 探索Spinosyn A衍生物作为ASS1激活剂和瘤抑制剂的结构-活性关系 (SAR).
- 为了确定增强抗癌活性的关键结构修改.
主要方法:
- 合成了25种新型的Spinosyn A衍生物,在原子上进行了修改.
- 对ASS1激活和抗瘤作用的衍生物的生物评估.
主要成果:
- 在化合物激活ASS1的能力和它们的抗瘤功效之间观察到强烈的相关性.
- 通过在二甲基-Spinosyn A. 的原子上引入特定的氨基侧链来实现最佳的抗瘤活性.
- 几种衍生品表现出强大的瘤抑制和ASS1激活.
结论:
- 对Spinosyn A的结构修改可以显著增强其作为ASS1激活剂和抗癌剂的功能.
- 已识别的衍生品代表了开发针对ASS1.1的新型癌症疗法的有希望的线索.
- 对Spinosyn A衍生物的进一步研究可能会导致癌症治疗的新疗法策略.
相关概念视频
The JAK-STAT Signaling Pathway
11.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.9K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Eukaryotic Transcription Inhibitors
10.9K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.9K
TGF - β Signaling Pathway
10.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K
Co-activators and Co-repressors
8.4K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.4K
Eukaryotic Transcription Activators
12.5K
Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
12.5K


